|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Number of the document | 3458084 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17725143.6 |
| Date of filing the European patent application | 2017-05-15 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/032714 |
| Date | 2017-05-15 |
| (87) | Number | WO 2017/200943 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 201662337005 P | 2016-05-16 | US | |
| 201662414146 P | 2016-10-28 | US | |
| 201662420937 P | 2016-11-11 | US |
| (72) |
BLACKWELL, William, US
SRIVASTAVA, Ved P., US
PAULIK, Mark A., US
YOUNG, Andrew, US
DOCK, Steven Thomas, US
HUNTER, III Robert Neil, US
|
| (73) |
Intarcia Therapeutics, Inc,
One Marina Park Drive 13th Floor, Boston, MA 02210,
US
|
| (54) | GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |
| GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |